Novavax plans to FINALLY submit data for 'protein based' COVID-19 vaccine to FDA

Novavax plans to finally submit clinical trial data for its COVID-19 vaccine to FDA regulators by the end of the year, seeking emergency use authorization for its shot.

from Health News | Mail Online https://ift.tt/3qi4yFE